Murein synthesis and beta-lactam antibiotic susceptibility during rod-to-sphere transition in a pbpA(Ts) mutant of Escherichia coli.

Antimicrobial Agents and Chemotherapy
G A Botta, D Buffa

Abstract

The conditional morphology mutant of Escherichia coli SP45 grows as a rod at 30 degrees C and assumes a spherical shape after 90 min of incubation at 42 degrees C. The rod-to-sphere morphological transition has been found to be associated with the disappearance of penicillin-binding protein 2 (PBP-2), the progressive reduction (as much as 50%) of murein synthesis, as measured both in intact cells and ether-permeabilized bacteria, and alterations in the structure of the cell envelope, including detachment of the outer membrane from the underlying structures. The detachment was initially localized at the poles of the cells and then spread over the entire surface. Shape transition was also linked to increased susceptibility to beta-lactam antibiotics which preferentially bound to PBP-1A (cephalothin, cephaloridine) or to PBP-3 (furazlocillin, piperacillin). Treatment with beta-lactams possessing a high affinity for PBP-1A, although inducing a low degree of peptidoglycan synthesis inhibition (5 to 10%), was associated with a marked loss of cell viability and massive lysis. On the other hand, the simultaneous absence of PBP-2 and inhibition of PBP-3 causes a significant reduction of peptidoglycan synthesis, yet only slightly affecte...Continue Reading

References

Dec 1, 1979·Antimicrobial Agents and Chemotherapy·K Kitano, A Tomasz
Jan 1, 1978·Journal of Bacteriology·M IwayaJ L Strominger
Jan 1, 1977·European Journal of Biochemistry·B G Spratt
Mar 1, 1977·Journal of Bacteriology·R Hakenbeck, W Messer
Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·S TamakiM Matsuhashi
Feb 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·H SuzukiY Hirota
Dec 1, 1978·Journal of Bacteriology·M IwayaJ L Strominger
Apr 16, 1973·Biochemical and Biophysical Research Communications·J T Park, L Burman
May 14, 1969·Journal of Molecular Biology·U SchwarzH Frank
Mar 1, 1966·Proceedings of the National Academy of Sciences of the United States of America·K IzakiJ L Strominger
Aug 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·T TamuraY Hirota

❮ Previous
Next ❯

Citations

Jan 1, 1997·Annual Review of Cell and Developmental Biology·D Bramhill
Sep 18, 2010·Cellular Microbiology·Verónica RegueiroJosé A Bengoechea
Dec 9, 2015·Journal of Bacteriology·Melissa E Reardon-Robinson, Hung Ton-That

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.